LYZZ Capital
Overview
LYZZ Capital is a venture capital firm specialized in seed, early, and expansion stage venture investments.
Investment Focus
- Focus on unmet medical needs
- Large market potential in China
- Innovative healthcare technologies
Portfolio Companies
Get the full list of 54,000+ investors
LYZZ Capital and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about LYZZ Capital
What sectors does LYZZ Capital invest in?
LYZZ Capital invests in Healthcare, Medical Devices, Medical Services and Medical Digitalization, and is based in China. LYZZ Capital is listed as a vc in the ConnectSafely investor database.
What stage does LYZZ Capital invest at?
LYZZ Capital backs companies at Seed and Early Stage.
Which regions does LYZZ Capital invest in?
LYZZ Capital invests across United States and China.
Who are the partners at LYZZ Capital?
Team members listed for LYZZ Capital include Kevin Li (Co-Founder and Managing Partner) and Xiakai Cheng (Principal).
What companies has LYZZ Capital invested in?
LYZZ Capital's portfolio includes Onchilles Pharma, Neurelis, Mojia Biotech, OncoMyx Therapeutics, JumpCode Genomics and Qpex Biopharma.
How do I contact LYZZ Capital?
LYZZ Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
